• 1
    Goldring SR. Bone and joint destruction in rheumatoid arthritis: what is really happening? [published erratum appears in J Rheumatol Suppl 2002;29:2471]. J Rheumatol Suppl 2002; 65: 448.
  • 2
    Abdel-Nasser AM, Rasker JJ, Valkenburg HA. Epidemiological and clinical aspects relating to the variability of rheumatoid arthritis [review]. Semin Arthritis Rheum 1997; 27: 12340.
  • 3
    Machold KP, Nell V, Stamm T, Aletaha D, Smolen JS. Early rheumatoid arthritis. Curr Opin Rheumatol 2006; 18: 2828.
  • 4
    Bray GA, Bellanger T. Epidemiology, trends, and morbidities of obesity and the metabolic syndrome [review]. Endocrine 2006; 29: 10917.
  • 5
    Schulte H, Cullen P, Assmann G. Obesity, mortality and cardiovascular disease in the Munster Heart Study (PROCAM). Atherosclerosis 1999; 144: 199209.
  • 6
    Wannamethee SG, Shaper AG, Durrington PN, Perry IJ. Hypertension, serum insulin, obesity and the metabolic syndrome. J Hum Hypertens 1998; 12: 73541.
  • 7
    Vanhala MJ, Pitkajarvi TK, Kumpusalo EA, Takala JK. Obesity type and clustering of insulin resistance-associated cardiovascular risk factors in middle-aged men and women. Int J Obes Relat Metab Disord 1998; 22: 36974.
  • 8
    Jinks C, Jordan K, Croft P. Disabling knee pain–another consequence of obesity: results from a prospective cohort study. BMC Public Health 2006; 6: 258.
  • 9
    Holmberg S, Thelin A, Thelin N. Knee osteoarthritis and body mass index: a population-based case-control study. Scand J Rheumatol 2005; 34: 5964.
  • 10
    Acar B, Uslu T, Topuz A, Osma E, Ercal T, Posaci C, et al. Relation between bone mineral content and clinical, hormonal and biochemical parameters in postmenopausal women. Arch Gynecol Obstet 1998; 261: 1218.
  • 11
    Orozco P, Nolla JM. Associations between body morphology and bone mineral density in premenopausal women. Eur J Epidemiol 1997; 13: 91924.
  • 12
    Smeets-Goevaers CG, Lesusink GL, Papapoulos SE, Maartens LW, Keyzer JJ, Weerdenburg JP, et al. The prevalence of low bone mineral density in Dutch perimenopausal women: the Eindhoven perimenopausal osteoporosis study. Osteoporos Int 1998; 8: 4049.
  • 13
    De Laet C, Kanis JA, Oden A, Johanson H, Johnell O, Delmas P, et al. Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int 2005; 16: 13308.
  • 14
    Kaufmann J, Kielstein V, Kilian S, Stein G, Hein G. Relation between body mass index and radiological progression in patients with rheumatoid arthritis. J Rheumatol 2003; 30: 23505.
  • 15
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 31524.
  • 16
    Rau R, Wassenberg S, Herborn G, Stucki G, Gebler A. A new method of scoring radiographic change in rheumatoid arthritis. J Rheumatol 1998; 25: 2094107.
  • 17
    Raspe HH, Hagedorn U, Kohlmann T, Mattussek S. Der Funktionsfragebogen Hannover (FFbH): ein instrument zur funktionsdiagnostik bei polyartikulären gelenkerkrankungen. In: SiegristJ, editor. Wohnortnahe betreuung rheumakranker: ergebnisse sozialwissenschaftlicher evaluation eines modellversuchs. Stuttgart: Schattauer; 1990. p. 16482.
  • 18
    Prevoo ML, van't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight–joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 448.
  • 19
    Felson DT, Zhang Y, Hannan MT, Anderson JJ. Effects of weight and body mass index on bone mineral density in men and women: the Framingham study. J Bone Miner Res 1993; 8: 56773.
  • 20
    Ravn P, Cizza G, Bjarnason NH, Thompson D, Daley M, Wasnich RD, et al, for the Early Postmenopausal Intervention Cohort (EPIC) study group. Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women. J Bone Miner Res 1999; 14: 16227.
  • 21
    Siris ES, Miller PD, Barrett-Connor E, Faulkner KG, Wehren LE, Abbott TA, et al. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. JAMA 2001; 286: 281522.
  • 22
    Tremollieres FA, Pouilles JM, Ribot C. Vertebral postmenopausal bone loss is reduced in overweight women: a longitudinal study in 155 early postmenopausal women. J Clin Endocrinol Metab 1993; 77: 6836.
  • 23
    Castracane VD, Kraemer GR, Ogden BW, Kraemer RR. Interrelationships of serum estradiol, estrone, and estrone sulfate, adiposity, biochemical bone markers, and leptin in post-menopausal women. Maturitas 2006; 53: 21725.
  • 24
    Oh KW, Lee WY, Rhee EJ, Baek KH, Yoon KH, Kang MI, et al. The relationship between serum resistin, leptin, adiponectin, ghrelin levels and bone mineral density in middle-aged men. Clin Endocrinol (Oxf) 2005; 63: 1318.
  • 25
    Scariano JK, Garry PJ, Montoya GD, Chandani AK, Wilson JM, Baumgartner RN. Serum leptin levels, bone mineral density and osteoblast alkaline phosphatase activity in elderly men and women. Mech Ageing Dev 2003; 124: 2816.
  • 26
    Gunaydin R, Kaya T, Atay A, Olmez N, Hur A, Koseoglu M. Serum leptin levels in rheumatoid arthritis and relationship with disease activity. South Med J 2006; 99: 107883.
  • 27
    Nishiya K, Nishiyama M, Chang A, Shinto A, Hashimoto K. Serum leptin levels in patients with rheumatoid arthritis are correlated with body mass index. Rinsho Byori 2002; 50: 5247.In Japanese.
  • 28
    Kaufmann J, Kielstein V, Kilian S, Stein G, Hein G. Relation between body mass index and radiological progression in patients with rheumatoid arthritis. J Rheumatol 2003; 30: 23505.
  • 29
    Escalante A, Haas RW, del Rincon I. Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation. Arch Intern Med 2005; 165: 16249.
  • 30
    Dayer JM, Chicheportiche R, Juge-Aubry C, Meier C. Adipose tissue has anti-inflammatory properties: focus on IL-1 receptor antagonist (IL-1Ra). Ann N Y Acad Sci 2006; 1069: 44453.
  • 31
    Juge-Aubry CE, Somm E, Giusti V, Pernin A, Chicheportiche R, Verdumo C, et al. Adipose tissue is a major source of interleukin-1 receptor antagonist: upregulation in obesity and inflammation. Diabetes 2003; 52: 110410.
  • 32
    Otero M, Lago R, Gomez R, Dieguez C, Gomez-Reino JJ, Gualillo O. Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann Rheum Dis 2006; 65: 1198201.
  • 33
    Garcia-Poma A, Segami MI, Mora CS, Ugarte MF, Terrazas HN, Rhor EA, et al. Obesity is independently associated with impaired quality of life in patients with rheumatoid arthritis. Clin Rheumatol 2007. E-pub ahead of print.